Kiersten Leigha Longchamps is a Omaha, Nebraska based nurse practitioner. Active license number of Kiersten Leigha Longchamps is 114315 in Nebraska. Her current practice location is 4350 Dewey Ave, Omaha. Patients can reach her at 402-552-2000. Kiersten Leigha Longchamps is AGACNP/APRN and her NPI number (Unique professional ID assigned by NPPES) is 1043946171. Kiersten Leigha Longchamps has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Kiersten Leigha Longchamps speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1043946171
NPI Enumeration Date:
29 Jul, 2022
NPI Last Update On:
29 Jul, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kiersten Leigha Longchamps are as mentioned below.
License Number
Specialization
State
Status
114315
Nebraska
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Kiersten Leigha Longchamps 988102 Nebraska Medical Ctr, Omaha, Nebraska
Zip:
68198-8102
Patients can reach Kiersten Leigha Longchamps at 4350 Dewey Ave, Omaha, Nebraska or can call to book an appointment on 402-552-2000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 March, 2025.